These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18384909)

  • 1. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.
    Huang W; Cordoro KM; Taylor SL; Feldman SR
    J Am Acad Dermatol; 2008 Jun; 58(6):970-7. PubMed ID: 18384909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.
    Ahn CS; Dothard EH; Garner ML; Feldman SR; Huang WW
    J Am Acad Dermatol; 2015 Sep; 73(3):420-8.e1. PubMed ID: 26184440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
    Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D; Strober BE
    Semin Cutan Med Surg; 2010 Mar; 29(1):28-34. PubMed ID: 20430305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.
    Lebwohl M; Bagel J; Gelfand JM; Gladman D; Gordon KB; Hsu S; Kalb RE; Kimball AB; Korman NJ; Krueger GG; Mease P; Morison WL; Paller A; Pariser DM; Ritchlin C; Strober B; Van Voorhees A; Weinstein GD; Young M; Horn L
    J Am Acad Dermatol; 2008 Jan; 58(1):94-105. PubMed ID: 17980456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.
    Guibal F; Iversen L; Puig L; Strohal R; Williams P
    Curr Med Res Opin; 2009 Dec; 25(12):2835-43. PubMed ID: 19916728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of the evidence-based guidelines for psoriasis--a project of the German Dermatological Society (DDG)].
    Follmann M; Sterry W; Rzany B; ;
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):678-89. PubMed ID: 16173975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic agents in nail psoriasis: efficacy data and considerations.
    Kyriakou A; Patsatsi A; Sotiriadis D
    Expert Opin Biol Ther; 2013 Dec; 13(12):1707-14. PubMed ID: 24156504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
    Price J; Bhosle M; Feldman SR; Balkrishnan R
    J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines.
    Nast A; Spuls PH; Ormerod AD; Reytan N; Saiag PH; Smith CH; Rzany B
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):782-7. PubMed ID: 19298485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
    Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
    J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The biological treatments for moderate to severe plaque psoriasis].
    Thielen AM; Marazza G
    Rev Med Suisse; 2008 Apr; 4(155):1089-90, 1092-4. PubMed ID: 18610721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.
    Reich K; Griffiths C; Barker J; Chimenti S; Daudén E; Giannetti A; Gniadecki R; Katsambas A; Langley R; Mrowietz U; Ogilvie A; Ortonne JP; Reider N; Saurat JH
    Dermatology; 2008; 217(3):268-75. PubMed ID: 18685261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 5. Diagnostic accuracy studies.
    Manchikanti L; Derby R; Wolfer L; Singh V; Datta S; Hirsch JA
    Pain Physician; 2009; 12(3):517-40. PubMed ID: 19461821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.
    Nast A; Erdmann R; Pathirana D; Rzany B
    J Eval Clin Pract; 2008 Oct; 14(5):803-6. PubMed ID: 19018914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
    Sobell JM; Kalb RE; Weinberg JM
    J Drugs Dermatol; 2009 Feb; 8(2):147-54. PubMed ID: 19213230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.